Chromenone-based GSK-3ß inhibitors as potential therapeutic targets for cardiovascular diseases: In silico study, molecular dynamics, and ADMET profiles

Glycogen synthase kinase-3 beta (GSK-3ß) regulates glycogen metabolism and many different cellulars, including apoptosis, signaling, and neural. It is a crucial therapeutic receptor in heart disease, type 2 diabetes, and Alzheimer’s. In this study, using computational methods, flavonoid compounds we...

Full description

Saved in:
Bibliographic Details
Main Authors: Min Zhang, San Zhou, Noor H. Obaid, Usama S. Altimari, Mohanad Adel Mohammed, Ahmed Kareem Obaid Aldulaim, Emad Salaam Abood, Hossam Kotb, Ayesheh Enayati, Vahid Khori, Hassan Mirzaei, Aref Salehi, Alireza Soltani, Mohd Sani Sarjadi, Md. Lutfor Rahman
Format: Article
Language:English
English
Published: Elsevier B.V. 2022
Subjects:
Online Access:https://eprints.ums.edu.my/id/eprint/35099/1/ABSTRACT.pdf
https://eprints.ums.edu.my/id/eprint/35099/2/FULL%20TEXT.pdf
https://eprints.ums.edu.my/id/eprint/35099/
https://www.sciencedirect.com/science/article/pii/S1878535222006049
https://doi.org/10.1016/j.arabjc.2022.104288
Tags: Add Tag
No Tags, Be the first to tag this record!